Results of the MARIPOSA-2 Study for Advanced Lung Cancer
The latest advancements in cancer treatment are offering new hope to patients with advanced non-small cell lung cancer (NSCLC), especially those with specific genetic mutations. This news report focuses on the MARIPOSA-2 study, an...
Decoding cell fate: Key mechanism in stem cell switch identified
Stem cells can differentiate to replace dead and damaged cells. But how do stem cells decide which type of cell to become in a given situation? Using intestinal organoids, the group of Bon-Kyoung Koo...
‘Strange metal’ is strangely quiet in noise experiment
HOUSTON – (Nov. 23, 2023) – True to form, a “strange metal” quantum material proved strangely quiet in recent quantum noise experiments at Rice University. Published this week in Science, the measurements of quantum...
Separating out signals recorded at the seafloor
Blame it on plate tectonics. The deep ocean is never preserved, but instead is lost to time as the seafloor is subducted. Geologists are mostly left with shallower rocks from closer to the shoreline...
AmoyDx and CST Expand Existing Partnership for the Development of Companion Diagnostics (CDx) to...
Cell Signaling Technology (CST), a life science biotechnology company and leading provider of antibodies, kits, and services, and Amoy Diagnostics Co., Ltd. (AmoyDx), a China-based innovative molecular diagnostics company in the field of precision oncology,...
Professor Tao Jun’s team at Yangzhou University analyses the molecular mechanism of PoWRKY71 in...
Paeonia ostii is a widely grown woody crop with up to 40% α-linolenic acid in its seed oil, which is beneficial to human health. Drought is a major environmental factor limiting the popularisation of P. ostii in hilly...
Repurposed drugs hold promise for targeting cancer stem cells
In a review published in the journal Genes & Diseases, researchers from ICMR-National Institute of Nutrition (NIN), advocate for the repurposing of non-cancer drugs to target these elusive CSCs. By focusing on drugs that...
Vivodyne’s Lab Grown Human Tissue Platform Gets Real with $38 Million Seed Financing
By: Julianna LeMieux, PhD
Andrei Georgescu, PhD, CEO of Vivodyne, was hoping to couple his interests in science and engineering when he chose UPenn for his graduate research. His goal was to build on his...
Immunotherapy drug is well tolerated in lung cancer patients with limited physical function, study...
For patients with advanced or metastatic non-small cell lung cancer (NSCLC) and limited performance status, an immune checkpoint inhibitor drug called durvalumab is safe and may benefit overall survival, according to a new eClinicalMedicine...
Biotech around the World: The West Coast of the United States
GEN begins an exploration of many of the world’s top biotech hubs starts. We’ve labeled the series Biotech around the World. The first article begins on the U.S. West Coast, talking with local execs...
